StockIQ.techGSK plc (GSK.L) Stock Analysis
Free AI-powered analysis and research for GSK plc stock
Sector: Healthcare
GSK.L snapshot
Data as of 3 Nov 2026 close. Updated daily.
GSK plc scores 44/100 on StockIQ's model, which reads as mixed signals overall. The price is below its 200-day average and at 23% of its 52-week range, up 4.0% over the past year. Latest reported figures show a profit margin of 13.0%, return on equity of 28.3% and revenue growth of +4.0%.
What is driving the score
- RSI Neutral: +5
- Flat Trend: -2
- MACD Bearish: -8
- Good Profit Margin (13.0%): +5
- Low Liquidity (0.86 Current Ratio): -10
- Excellent ROE (28.3%): +8
- Below MA200: -4
- Up Over 1 Year (+4.0%): +3
- Low Volume (0.5x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full GSK.L report
GSK plc (GSK.L) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze GSK.L Now →📰 Latest Update
What GSK (GSK) Said on Its Q3 Earnings Call
Wed, October 28, 2026 at 6:04 PM UTC 3 min read
During its Q3 earnings call, GSK reported a 10% increase in revenue, driven by strong sales in its vaccine and specialty medicines segments. The company also raised its full-year guidance, reflecting confidence in its product pipeline and market demand. This positive outlook is significant for investors, as it suggests potential for sustained growth and profitability in the coming quarters.